Advanced9 min readHigh Yield

Alcohol Withdrawal Syndrome - CCS Case Guide

Key Takeaway: Alcohol withdrawal syndrome occurs in patients with chronic heavy alcohol use who abruptly reduce or stop intake. The clinical spectrum ranges from mild tremulousness (6-24 hours) to withdrawal seizures (12-48 hours) and delirium tremens (48-96 hours).

Alcohol withdrawal syndrome occurs in patients with chronic heavy alcohol use who abruptly reduce or stop intake. The clinical spectrum ranges from mild tremulousness (6-24 hours) to withdrawal seizures (12-48 hours) and delirium tremens (48-96 hours). Mortality from untreated delirium tremens can exceed 35%. Early recognition, CIWA-based symptom-triggered benzodiazepine therapy, and aggressive nutritional support are the cornerstones of management on the CCS exam.

Recognizing the Alcohol Withdrawal Presentation

  • History: Chronic heavy alcohol use with abrupt cessation or significant reduction in intake within past 24-96 hours; history of prior withdrawal seizures or DTs increases risk
  • Autonomic: Tremor (especially hands), diaphoresis, tachycardia, hypertension, and low-grade fever
  • Neuropsychiatric: Anxiety, agitation, insomnia, nausea/vomiting, and irritability in early withdrawal
  • Seizures: Generalized tonic-clonic seizures typically occurring 12-48 hours after last drink, often in brief clusters
  • Delirium Tremens: Severe agitation, global confusion, vivid hallucinations (visual > tactile > auditory), autonomic hyperactivity, and profound diaphoresis occurring 48-96 hours after last drink
  • Physical Exam: Coarse tremor, hyperreflexia, diaphoresis, conjunctival injection, and signs of chronic liver disease (spider angiomata, palmar erythema, hepatomegaly)
  • Vital Signs: Tachycardia, hypertension, tachypnea, and fever (especially with DTs)

Immediate Actions (First 5 Minutes)

These orders should be placed immediately — timing is scored:

Critical First Orders

  • IV access and continuous telemetry monitoring
  • Initiate CIWA-Ar protocol with assessments every 1-2 hours
  • Administer thiamine 500 mg IV before any glucose-containing fluids
  • Administer IV benzodiazepine (chlordiazepoxide or lorazepam) for CIWA score >= 10
  • IV normal saline bolus for volume depletion
  • Fingerstick glucose to rule out hypoglycemia
  • Place seizure precautions
  • Obtain stat BMP, CBC, magnesium, phosphate, LFTs

Complete Workup

After initial stabilization, complete the diagnostic workup:

  • BMP (glucose, electrolytes, BUN/creatinine)
  • CBC with differential
  • Hepatic function panel (AST, ALT, GGT, alkaline phosphatase, albumin, bilirubin)
  • Magnesium and phosphate levels
  • Coagulation studies (PT/INR)
  • Blood alcohol level
  • Urine drug screen
  • Lipase (pancreatitis is common comorbidity)
  • Serum ammonia if altered mental status
  • CT head if first seizure, focal neurological deficits, or head trauma
  • Chest X-ray if fever or respiratory symptoms (aspiration risk)
  • ECG for QTc prolongation and electrolyte-related arrhythmias

Treatment

Benzodiazepines (CIWA-guided)

  • Chlordiazepoxide 25-100 mg PO every 4-6 hours for CIWA 10-18 (mild-moderate)
  • Lorazepam 2-4 mg IV every 15-30 minutes for CIWA >= 20 or severe symptoms
  • Lorazepam preferred in hepatic dysfunction (no hepatic metabolism)
  • Diazepam 10-20 mg IV for rapid control in severe withdrawal or DTs
  • Phenobarbital 130-260 mg IV as adjunct for benzodiazepine-refractory cases

Nutritional Repletion

  • Thiamine 500 mg IV three times daily for 3 days (high-dose Wernicke prophylaxis)
  • Folic acid 1 mg PO daily
  • Multivitamin daily
  • Magnesium sulfate 2 g IV if hypomagnesemia
  • ALWAYS give thiamine BEFORE glucose to prevent Wernicke encephalopathy

Supportive Care

  • IV normal saline for volume repletion
  • NPO if actively seizing or severely altered
  • Correct electrolyte abnormalities (potassium, magnesium, phosphate)
  • DVT prophylaxis once stable

Seizure and DT Management

  • Lorazepam 2-4 mg IV for active seizures
  • Do NOT use phenytoin for isolated alcohol withdrawal seizures (ineffective)
  • ICU admission for delirium tremens with aggressive IV benzodiazepine dosing
  • Consider propofol or dexmedetomidine for ICU-level refractory DTs
  • Mechanical ventilation if airway compromise from sedation or DTs

Common Pitfalls

Scoring Tip: These are the most commonly missed actions for Alcohol Withdrawal cases.

  • Giving glucose before thiamine, precipitating acute Wernicke encephalopathy
  • Using phenytoin for alcohol withdrawal seizures (it is ineffective; benzodiazepines are the treatment)
  • Using a fixed-dose benzodiazepine schedule instead of symptom-triggered CIWA protocol
  • Failing to recognize delirium tremens as distinct from simple withdrawal (DTs have global confusion and hallucinations)
  • Discharging too early without adequate observation (DTs can present 48-96 hours after last drink)
  • Not checking magnesium, which can lower seizure threshold if depleted
  • Missing concurrent pathology (subdural hematoma, pancreatitis, GI bleeding) in an altered patient

Disposition

  • Admit to ICU for delirium tremens, refractory seizures, or hemodynamic instability
  • Admit to medical floor for moderate withdrawal requiring frequent CIWA monitoring
  • Observe in ED for 6-8 hours for mild withdrawal (CIWA < 10) before safe discharge
  • Arrange addiction medicine or substance abuse counseling referral at discharge
  • Schedule outpatient follow-up within 1 week with primary care

Key Orders Checklist

  • CIWA-Ar protocol every 1-2 hours
  • Chlordiazepoxide or lorazepam per CIWA protocol
  • Thiamine 500 mg IV TID x 3 days
  • Folic acid 1 mg PO daily
  • Multivitamin PO daily
  • BMP and magnesium every 12 hours
  • Seizure precautions
  • Continuous telemetry
  • Blood alcohol level on admission
  • Strict I/O monitoring
  • Fall precautions

Practice Alcohol Withdrawal Cases

Apply these strategies with our realistic Alcohol Withdrawal simulations and get instant AI feedback.

Try a Free Case